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INTRODUCTION
In spayed, female dogs, urinary incontinence (UI) 
is a common condition with a reported prevalence be-
tween 3.1 and 20.1% (Arnold et al., 1989; O’Neill et 
al., 2017). The majority of dogs with acquired UI suf-
fer from urethral sphincter mechanism incompetence 
(USMI) (Byron et al., 2017). The first treatment op-
tion in dogs affected by acquired UI is medical mana-
gement. Although some cases become refractory to 
treatment, medical management is highly efficient in 
many cases. (Applegate et al., 2018). Urinary incon-
tinence and subsequent medical management have 
been discussed in more detail in a previous literature 
review article published in this journal (Timmermans 
et al., 2019). 
     BSTRACT
Urinary incontinence is a common condition in spayed, female dogs with a reported preva-
lence between 3.1% and 20.1%. In the majority of dogs with acquired urinary incontinence, ure-
thral sphincter mechanism incompetence is the underlying cause. Approximately 15% of bitches 
that initially respond to medical therapy ultimately become refractory. Surgical intervention is 
indicated when patients do not respond or become refractory to medical treatment. Based on the 
current literature, placement of an artificial urethral sphincter, i.e. an inflatable cuff around the 
proximal urethra connected to a subcutaneous injection port, provides a very reliable and long-
term incontinence resolution in bitches and has a low complication rate.
SAMENVATTING
Urinaire incontinentie is een vaak voorkomende aandoening bij gesteriliseerde teven met een ge-
rapporteerde prevalentie tussen 3,1% en 20,1%. Bij de meeste honden met verworven urinaire inconti-
nentie is er sprake van een onderliggende urethrale sfinctermechanisme-incompetentie. Ongeveer 15% 
van de teven die initieel verbeteren met medicamenteuze behandeling, wordt uiteindelijk refractair. 
Chirurgische interventie is aangeraden wanneer patiënten niet verbeteren ondanks medicamenteuze 
behandeling of refractair worden aan medicamenteuze behandeling. Gebaseerd op de huidige literatuur 
biedt de plaatsing van een artificiële urethrale sfincter, dit is een opblaasbare “cuff” rondom de proxi-
male urethra die verbonden is met een subcutane injectiepoort, een zeer betrouwbare en langdurige 
oplossing voor incontinentie bij teven, waarbij zelden complicaties optreden. 
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Historically, different surgical options have been 
researched. In this review, indications for surgical 
treatment in patients with acquired UI due to USMI 
are highlighted and the currently available surgical 
options are discussed.
SURGICAL TREATMENT
Surgical treatment is indicated 1. when patients do 
not respond to medical treatment or encounter severe 
adverse effects from it, 2. to treat refractory urinary 
incontinence, or 3. when owners are reluctant to ad-
minister lifelong medication. A large number of dogs 
with USMI are eventually presented as candidates for 
surgical treatment, since approximately 15-20% of 
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bitches that initially respond to medical therapy ul-
timately become refractory (Scott et al., 2002; Adin, 
2014). Additionally, until recently, most surgical 
procedures could not provide long-term continence; 
however, technological advances seem to have elimi-
nated this problem.
Colposuspension
Colposuspension is essentially a vaginopexy that 
entraps the urethra between the vagina and the ab-
dominal wall using nonabsorbable, monofilament 
suture material (Mcloughlin and Chew, 2009; Claeys 
et al., 2010b). Increased external compression of the 
proximal urethra is caused both by the compressive 
effect from the vaginopexy and also by the reposition-
ing of both the bladder neck and proximal urethra into 
a more cranial intra-abdominal position (Rawlings et 
al., 2001; Applegate et al., 2018) (Figure 1). 
Short-term continence is achieved in approxima-
tely 55% of cases. However, in a study by Rawlings 
et al. (2001), continence decreased to 14% one year 
postoperatively (n = 23 dogs). Additional medical 
therapy resulted in regained continence in a total of 
38% of dogs after one year (Rawlings et al., 2001) 
(Table 1).
Major complications, including (partial) urethral 
obstruction, are rare (Rawlings et al., 2001; Mclough-
lin and Chew, 2009). Transient dysuria is the most 
commonly observed minor complication. 
Figure 1. Schematic representation of the colposuspen-
sion technique illustrating how the vaginopexy (pink) 
compresses the urethra (orange) to the abdominal wall 
(grey). 
Figure 2. Schematic representation of the urethropexy 
technique illustrating how the procedure is reducing the 
diameter of the urethral lumen (orange). 
Table 1. Data summary of surgical treatment options of refractory incontinence other than the artificial urethral 
sphincter. 
 n Follow-up Short-term Long-term Compli- Owner
  (months) continence  continence cations satis-
      faction
 
    SX SX + MED SX SX + MED Minor Major 
Colposuspension         
 Rawlings et al. (2001) 23 12 55% N/A 14% 38% N/A N/A 83%
Urethro(cysto)pexy         
 Massat et al. (1993) 10 14 N/A 40% 10% 30% 20% 0 60%
 White (2001) 100 54 N/A N/A 56%† -  20% 3% 77%†
Urethropexy and colposuspension         
 Martinoli et al. (2014) 30 39 N/A N/A 70% N/A 10% 0 97%
Urethral bulking         
 Barth et al. (2005) 40 12 68% 83% 28% 65% 15% 0 70%
 Bartges and Callens (2011) 22 1 77% - N/A N/A 18% 0 N/A
 Byron et al. (2011) 21* 56 N/A N/A N/A N/A N/A N/A N/A
Transobturator vaginal tape         
 Claeys et al. (2010) 7 11 71% 85% 71% 85% 14% 0 85%
 Deschamps and Roux (2015) 12 48 92% N/A 25% -  58% 25% 83%
 Hamon et al. (2019) 12 85 83% - 40%‡ 80%‡ 17% 0 80%‡ 
Short-term continence < 6 months; long-term continence > 6 months, SX: surgery, SX + MED: surgery and medication, N/A: data not avail-
able in the publication, *Study on a total of 31 dogs of which 21 patients with USMI, †40 out of 100 dogs were excluded from long-term 
analysis, ‡2 out of 12 dogs were excluded from long-term analysis.
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Urethro(cysto)pexy
Urethropexy consists of attaching the urethra to 
the ventral abdominal wall whereas with cystoure-
thropexy, both the urethra and the bladder are attached 
to the abdominal wall (Mcloughlin and Chew, 2009). 
Nonabsorbable monofilament sutures are used in 
these techniques (Mcloughlin and Chew, 2009). Dur-
ing both procedures, the bladder neck and proximal 
urethra are repositioned more cranially in the abdo-
men. When performing a urethropexy, the diameter of 
the urethral lumen is reduced, creating higher urinary 
flow resistance (Massat et al., 1993; Mcloughlin and 
Chew, 2009) (Figure 2). 
A prospective study on urethropexy performed 
by White (2001) revealed 87% short-term improve-
ment (n = 100 dogs). However, long-term continence 
decreased to 56% approximately three years postop-
eratively (Table 1). Unfortunately, the effects of ad-
ditional medical treatment following a urethropexy 
were not evaluated in the study by White (2001). Re-
sults after cystourethropexy are less positive than the 
urethropexy results, with only 10% continence after 
surgery and 30% long-term continence when phenyl-
propanolamine was administered (n = 10 dogs) (Mas-
sat et al., 1993).
Major complications are rare, with 3% of affected 
dogs requiring revision surgery due to anuria or avul-
sion of the urethropexy site (White, 2001; Martinoli 
et al., 2014). Minor complications are common, oc-
curring in 20% of affected dogs, and include transient 
pollakiuria and dysuria. 
Martinoli et al. (2014) described the combination 
of urethropexy and colposuspension in female dogs 
with refractory UI (n = 30 dogs) and found higher 
success rates compared to the rates found when either 
of these techniques were used alone. In that study, the 
combination therapy achieved long-term continence 
in 70% of dogs after a median follow-up of approxi-
mately 39 months. Complications were mild and tem-
porary in 10% of cases. Remarkably, combining these 
two techniques is likely to decrease the risk of avul-
sion; this combination has been successful in bitches 
with previous avulsion of the soft tissues (Martinoli 
et al., 2014). 
Urethral bulking 
Urethral bulking is a minimally invasive treatment 
method where bulking agents are injected into the ure-
thral submucosa (Arnold et al., 1996). Under videoen-
doscopic guidance, the bulking agents are injected in 
the proximal urethra at the 2-, 6-, and 10-o’clock po-
sitions to increase the urethral closure pressure (Klar-
skov and Lose, 2008; Byron et al., 2011; Applegate 
et al., 2018) (Figure 3). Bovine glutaraldehyde cross-
linked collagen used to be the gold standard (Bartges 
and Callens, 2011; Byron et al., 2011), but is no lon-
ger available on the European market (Lüttmann et 
Figure 3. Videoendoscopic view of urethral bulking 
during (left) and after (right) injection of bulking agents 
(From: Applegate et al., 2018).
Figure 4. Schematic representation illustrating the 
placement of the transobturator vaginal tape using the 
inside-out variant (From: Deschamps and Roux, 2015).
al., 2019). In a study by Bartges and Callens (2011), 
polydimethylsiloxane was used as an alternative. In 
that study, 22 female dogs, of which 77% were conti-
nent, were included; there was a follow-up period of 
only one month (Bartges and Callens, 2011). Recent-
ly, continence results after endoscopic urethral injec-
tions of dextranomer/hyaluronic acid copolymer have 
been reported by Lüttmann et al. (2019). Their find-
ings identified the new copolymer as a valuable sub-
stitution. However, it provided a shorter duration of 
continence than bovine glutaraldehyde cross-linked 
collagen (Lüttmann et al., 2019).
Efficacy of solo-treatment with urethral injections 
is approximately 60-70%, but rises to 83% when dogs 
simultaneously receive alpha-adrenergic agonists, 
such as phenylpropanolamine (Barth et al., 2005; By-
ron et al., 2011) (Table 1). Over time, migration and 
flattening of the material in the mucosa occur, leading 
to a 40%-decrease in efficacy after one year of inject-
ing collagen and the recurrence of UI (n = 40 dogs) 
(Barth et al., 2005). To assure life-long continence, 
repeated injections are required (Byron et al., 2011).
No major complications, meaning patients re-
quiring revision surgery, have been reported. Minor 
complications, usually of transient nature, occur in 
approximately 15% of patients that underwent ure-
thral bulking and include stranguria, hematuria, and 
vaginitis (Barth et al., 2005; Lüttmann et al., 2019). 
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Transobturator vaginal tape
The technique was first described in women by 
Cho et al. (2011). Its most recent modification, the 
transobturator vaginal tape inside-out variant, is cur-
rently used in veterinary medicine (Claeys et al., 
2010a; Hamon et al., 2019) (Figure 4). A polypropy-
lene tape is applied around the distal third of the ure-
thra using a specific needle and polyethylene tubes as 
a guide (Claeys et al., 2010a). The exact mechanism 
of action remains unclear, but increased periurethral 
tension due to the foreign body or an inflammatory 
response induced by the device might be the reason 
for regaining continence (Hamon et al., 2019). 
In a study by Claeys et al. (2010a) including seven 
dogs, a complete continence was observed in 86% 
of patients after a mean follow-up of eleven months 
(Claeys et al., 2010a) (Table 1). Although Deschamps 
and Roux (2015) reported a complete urinary conti-
nence in eleven out of twelve dogs (92%) within two 
weeks after surgery, long-term results revealed com-
plete long-term continence in only 25% of the dogs 
and an additional 25% of patients with major im-
provement at a median follow-up of four years. In a 
more recent study by Hamon et al. (2019), more posi-
tive results were reported, with complete continence 
in four out of ten dogs at a median follow-up of seven 
years (n = 12 dogs). However, two dogs in that study 
were excluded from the long-term analysis due to fac-
tors outside of the study’s control. Additional medical 
treatment consisted of phenylpropanolamine, oestro-
gen or a combination of both. Due to this additional 
treatment, the continence rates of four out of the six 
remaining dogs that were not responding to solo treat-
ment, improved (Hamon et al., 2019). 
In a study by Deschamps and Roux (2015), major 
complications, such as fistula formation, occurred in 
three out of twelve dogs (25%) and required implant 
removal; however these complications did not occur 
in the two other studies (Claeys et al., 2010; Hamon 
et al., 2019). Minor complications occurred in 14-
58% of patients and included transient dysuria and an 
iatrogenic urethral tear (Claeys et al., 2010; Des-
champs and Roux, 2015; Hamon et al., 2019). 
Artificial urethral sphincter
The artificial urethral sphincter (AUS) consists of 
an inflatable silicone cuff placed around the urethra 
that is connected to a subcutaneous access port (Adin 
et al., 2004) (Figure 5). The device is available in dif-
ferent sizes depending on the diameter of the urethra, 
which is measured either preoperatively via ultraso-
nographic examination or intraoperatively. 
Tapered cuff inflation with sterile saline, adapted 
to the individual patient, is a unique advantage com-
pared to other surgical techniques. In approximately 
25-50% of patients, continence is regained due to the 
semi-rigid structure of the cuff and the more intra-
abdominal position of the bladder (Rose et al., 2009). 
However, in dogs that remain incontinent four to six 
weeks postoperatively, inflation of the silicone cuff 
with 0.1–0.2 ml increments is performed (Reeves et 
al., 2013). According to a cadaveric study performed 
by Adin et al. (2004), the minimum volume to obtain 
complete occlusion of the lumen of the AUS cuff is 
0.4 ml. Interestingly, recent studies show that higher 
total cuff inflation volumes of up to 2 ml might be re-
quired to achieve continence and can be tolerated by 
patients without adverse effects (Gomes et al., 2018; 
Morgan et al., 2018). In the event of side effects, 
such as stranguria or pollakiuria, the cuff can easily 
be deflated via the subcutaneous access port (Rose et 
al., 2009; Delisser et al., 2012; Currao et al., 2013; 
Gomes et al., 2018; Morgan et al., 2018).
Long-term continence rates in the literature vary 
between 28-100% (Rose et al., 2009; Delisser et al., 
2012; Currao et al., 2013; Gomes et al., 2018; Morgan 
et al., 2018) (Table 2). When interpreting these results 
and comparing them with other surgical techniques, it 
is important to note that dogs with major improvement 
are not included in the continence rates. Delisser et al. 
(2012) for example found that 36% of the eleven dogs 
in their study were completely continent at the end of 
Table 2. Published results of the surgical treatment of refractory incontinence with an artificial urethral sphincter.
 n Follow-up Short-term Long-terme AUS       Complications Owner
  (months) continence continence cuff             cations  satis-
      inflation   faction
   SX SX + MED SX SX + MED  Minor Major 
Rose et al. (2009) 4 27 75% N/A 100% - 75% 75% 0 100%
Delisser et al. (2012) 11 14 27% N/A 36% - 55% 82% 0 73%
Currao et al. (2013) 18 32 N/A N/A 56% 77% 67% 44% 17% N/A
Reeves et al. (2013)  27 (3M) 13 N/A N/A N/A N/A 56% 37% 7% 89%
Gomes et al. (2018) 20 40 35% - 35% 40% 65% 65% 5% 90%
Morgan et al. (2018) 9 (2M) 27 N/A N/A 28% N/A 71% 14% 14% N/A
Short-term continence: < 6 months; long-term continence: > 6 months, SX: surgery, SX + MED: surgery and medication, N/A: data not 
available in the publication, M: male dogs. Only data from female dogs was evaluated when possible.
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Figure 5. Placement of an AUS. A. An overview of the individual components. B. The inflatable cuff is placed around 
the urethra distal to the trigone. C. The subcutaneous access port is placed in a subcutaneous pocket lateral to the 
mammary chain. D. Postoperative filling of the cuff with sterile saline using a dedicated needle.
A B
C D
the study. However, the median continence score of 
all dogs in that study was 9/10 (range, 7/10-10/10). 
In a recent study by Gomes et al. (2018) with a fol-
low-up of three years (range: 365-2.257 days), 40% of 
complete continence and another 50% with major im-
provement (n = 20 dogs) were shown. In other studies, 
similar continence scores have been reported (Delisser 
et al., 2012; Currao et al., 2013; Gomes et al., 2018; 
Morgan et al., 2018) and scores at two weeks, three 
and six months were 8 (4 to 10). Another important 
factor in the evaluation of the results of the AUS sys-
tem is the owner compliance (Currao et al., 2013). 
Final continence results may be lower due to owners 
deeming the situation clinically manageable and de-
clining further follow-up visits to fill the cuff until full 
continence is achieved (Reichler et al., 2006; Currao et 
al., 2013; Byron, 2015). Currao et al. (2013) reported 
a long-term complete continence rate of 56% in dogs 
approximately 2.5 years after placement, which in-
creased to 77% in cases with compliant owners allow-
ing continued cuff inflations (Table 2). 
Additional medical therapy should be considered 
when patients have recurrence of incontinence and 
have the cuff filled. Previous reports show a lot of 
variation in the need for additional medication, from 
0-61% (Delisser et al., 2012; Currao et al., 2013). The 
infrequent requirement of medical therapy after AUS 
placement is likely a result of the semi-rigid structure 
of the cuff, as mentioned by Rose et al. (2009).
Major complications, including urethral obstruc-
tion, urethral stricture, urethral laceration, implant 
failure by cuff leakage, or implant infection have 
been reported in 0-17% of cases (Rose et al., 2009; 
Delisser et al., 2012; Currao et al., 2013; Reeves et 
al., 2013; Gomes et al., 2018; Morgan et al., 2018). 
Treatment consists of device removal (Currao et al., 
2013). Minor complications are common (Delisser et 
al., 2012) and include dysuria, seroma formation and 
pain originating from the subcutaneous port. These 
complications are either transient or can be resolved 
with medications such as non-steroidals. Other minor 
complications such as stanguria require cuff deflation 
(Rose et al., 2009; Delisser et al., 2012; Currao et al., 
2013; Reeves et al., 2013).
CONCLUSION
Evaluation of the current literature shows that 
there is a large disparity between results. Compari-
son is therefore not always accurate. The AUS sys-
tem provides the best long-term results for the surgi-
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cal treatment of bitches with refractory UI, with most 
dogs achieving full continence. Cuff inflation allows 
individualized tapering until complete continence oc-
curs, although only 55-75% of patients will require 
inflation to achieve complete urinary continence. For 
dogs that do not achieve full continence, supplemen-
tary medical therapy can further improve the conti-
nence rates. 
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Uit het verleden
Gynaecologie: geen geschikte term in de diergeneeskunde
Het woord ‘gynaecologie’ wordt dikwijls gebruikt als synoniem voor verloskunde. Maar die 
tak van de (dier)geneeskunde is uiteraard veel ruimer. Dat weet iedereen. Etymologisch be-
tekent gynaecologie kennis (Grieks: logos) over de huisvrouw (Grieks gynè: vrouw; oikos: 
huis). De term verraadt dat eeuwenlang enkel het geslachtsleven en de daarmee gepaard gaan-
de ziektetoestanden van de huisvrouw - de getrouwde vrouw - voor de medische wetenschap 
van belang waren. ‘Geestelijke (geest-gelijke) dochters’, religieuzen, werden niet veronder-
steld een geslachtsleven te hebben en andere vrouwen waren uitschot, tenzij ze, bij voorkeur 
als jonge maagd, konden ‘dienen’ om huisvrouw te worden.
Gynaecologie: niet echt een geschikte term dus voor … diergeneeskundig gebruik. Maar wel-
ke dan wel?
Luc Devriese
